374 RESULTS
To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.
Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.
Sponsor: Office of Strategic Coordination (Common Fund)
Award: The NIH Common Fund intends to commit approximately $7.175 million in FY 2020 to fund one award.
Due Date: November 12 , 2019, by 5 p.m. local time of applicant organization.
Sponsor: National Institute of General Medical Sciences
Due Date: September 25, 2019; September 25, 2020; September 27, 2021, by 5 p.m. local time of applicant organization.
Sponsor: National Institute of General Medical Sciences
Due Date: September 25, 2019; September 25, 2020; September 27, 2021, by 5 p.m. local time of applicant organization.
Sponsor: Office of Strategic Coordination (Common Fund)
Award: The NIH Common Fund intends to commit approximately $6.8 million in FY 2020 to fund four awards.
Due Date: November 12, 2019, by 5 p.m. local time of applicant organization.
Sponsor: The Chan Zuckerberg Initiative
Award: Applicants can request funding between $50,000 and $250,000 for one year.
Due Date: CZI will invite applications during three distinct cycles, with rounds beginning June 18, 2019; mid-December 2019; and mid-June 2020.
Sponsor: National Institute on Aging, National Institute of Mental Health
Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019.
Sponsor: National Institute on Aging
Award: NIA intends to commit $787,500 in FY 2020 to fund two awards.
Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.
Sponsor: National Institute on Aging
Award: NIA intends to commit $3 million in FY 2020 to fund four to six awards.
Due Date: October 22, 2019, by 5 p.m. local time of applicant organization.
Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging
Award: NINDS intends to commit up to $3.75 million in FY 2020 to fund up to six awards.
Due Date: August 14, 2019, by 5 p.m. local time of applicant organization.
Sponsor: Chan Zuckerberg Initiative
Due Date: Letters of Interest due July 23, 2019.
Sponsor: Infectious Diseases Society of America (IDSA) Foundation
Award: The IDSA Foundation is offering up to five one-time, $100,000 grants to researchers working to identify a microbial link to Alzheimer’s disease.
Due Date: The application period for the grant will open on June 10, and remain open through November 30.
Sponsor: National Institute on Aging
Award: NIA intends to commit $3 million in FY 2020 to fund four to six awards.
Due Date: October 23, 2019, by 5 p.m. local time of applicant organization.
Sponsor: Alzheimer's Drug Discovery Foundation
Award: $50,000-$100,000 for epidemiological analyses based on scope of research. Up to $3 million for clinical trials based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.
Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019; Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.
Sponsor: Alzheimer's Drug Discovery Foundation
Award: Up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.
Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019, Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.
Sponsor: Alzheimer's Drug Discovery Foundation
Award: $150,000-$600,000 based on stage and scope of research. Larger amounts will be considered for PET ligand development for regulatory or clinical work. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.
Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019; Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.
No filters selected
